Apirachol,
Binazin,
Binazine,
Ecarazine,
Todralazine,
Todrazoline,
Todralazine hydrochloride,
Ecarazine,
3778-76-5,
Apirachol,
Binazin,
Binazine,
Ecarazine hydrochloride,
621-BT hydrochloride,
UNII-C59540FEXP,
CCRIS 5090,
C59540FEXP,
Todralazine HCl,
N1-Ethoxy carbonyl-N2-hydrazinophthalazine hydrochloride,
DSSTox_CID_24664,
DSSTox_RID_80385,
DSSTox_GSID_44664,
CARBAZIC ACID, 3-(1-PHTHALAZINYL)-, ETHYL ESTER, MONOHYDROCHLORIDE,
Hydrazinecarboxylicacid, 2-(1-phthalazinyl)-, ethyl ester, hydrochloride (1:1),
SR-01000841205,
NCGC00016640-03,
CAS-3778-76-5,
Todralazine hydrochloride [JAN],
Prestwick_899,
AC1L2EGT,
C11H13ClN4O2,
MLS002154190,
SCHEMBL211261,
SPECTRUM1501174,
CHEMBL1318529,
DTXSID4044664,
CTK4H8818,
HMS1568O03,
HMS1921N09,
Pharmakon1600-01501174,
Tox21_113562,
Tox21_301437,
2-(1-Phthalazinyl)-hydrazinecarboxylic acid ethyl ester hydrochloride,
CCG-40263,
NSC757868,
AKOS015963889,
AKOS024375001,
Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, monohydrochloride,
Tox21_113562_1,
ACM3778765,
API0013666,
MCULE-7836122954,
NSC-757868,
NCGC00016640-06,
NCGC00094919-01,
NCGC00094919-02,
NCGC00256213-01,
AC-18055,
LS-51663,
O389,
SMR001233481,
FT-0714739,
ST51015161,
D01951,
C-44334,
SR-01000841205-2,
SR-01000841205-3,
ethyl N-(phthalazin-1-ylamino)carbamate hydrochloride,
ethyl N-(phthalazin-1-ylamino)carbamate,hydrochloride,
Ethyl 2-(phthalazin-1-yl)hydrazinecarboxylate hydrochloride,
ethoxy-N-(2-hydrophthalazinylideneazamethyl)carboxamide, chloride,
Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, monohydrochloride (9CI),
todralazine,
Todralazinehydrochloride,
C11H12N4O2.ClH,
CID19604,
C11-H12-N4-O2.Cl-H,
14679-73-3,